NDC 0409-7447 - Cimetidine in Sodium Chloride

This NDC is not currently matched to an FDA NDC product listing in FDA.report, but it is a valid NDC-form code. FDA.report is showing the available DailyMed label context for the product root.

Product NDC: 0409-7447
Package NDCs from labels: 0409-7447-16
Manufacturer: HOSPIRA, INC.
Effective date: 2006-04-13
Current FDA listing: Not matched in FDA.report NDC product tables

DailyMed Labels#

Label, Manufacturer, Effective date table
Label	Manufacturer	Effective date	Type
CIMETIDINE in 0.9% Sodium Chloride Injection, USP	HOSPIRA, INC.	2006-04-13	Human prescription drug label

DailyMed Socrata Ingredients#

Ingredient, Type, UNII table
Ingredient	Type	UNII	DailyMed label	SPL version
Cimetidine	ACTIVE INGREDIENT	80061L1WGD	CIMETIDINE IN SODIUM CHLORIDE (CIMETIDINE AND SODIUM CHLORIDE) INJECTION, SOLUTION [HOSPIRA, INC.]	1
Cimetidine	ACTIVE MOIETY	80061L1WGD	CIMETIDINE IN SODIUM CHLORIDE (CIMETIDINE AND SODIUM CHLORIDE) INJECTION, SOLUTION [HOSPIRA, INC.]	1
Hydrochloric Acid	INACTIVE INGREDIENT	QTT17582CB	CIMETIDINE IN SODIUM CHLORIDE (CIMETIDINE AND SODIUM CHLORIDE) INJECTION, SOLUTION [HOSPIRA, INC.]	1
Sodium Chloride	INACTIVE INGREDIENT	451W47IQ8X	CIMETIDINE IN SODIUM CHLORIDE (CIMETIDINE AND SODIUM CHLORIDE) INJECTION, SOLUTION [HOSPIRA, INC.]	1
Sodium Hydroxide	INACTIVE INGREDIENT	55X04QC32I	CIMETIDINE IN SODIUM CHLORIDE (CIMETIDINE AND SODIUM CHLORIDE) INJECTION, SOLUTION [HOSPIRA, INC.]	1
Water	INACTIVE INGREDIENT	059QF0KO0R	CIMETIDINE IN SODIUM CHLORIDE (CIMETIDINE AND SODIUM CHLORIDE) INJECTION, SOLUTION [HOSPIRA, INC.]	1

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 5 of 14 · 264 matching rows.

Brand, Generic, Manufacturer table
Brand	Generic	Manufacturer	SPL set ID	Effective date	Available safety fields	Join
TAZICEF	CEFTAZIDIME	Hospira, Inc.	40d48c5d-650e-461b-a67b-7e65772d1b92	2026-05-04	Warnings, Adverse reactions	Name fallback manufacturer name: Hospira, Inc.
Hetastarch in Sodium Chloride	HETASTARCH	Hospira, Inc.	d64f961a-3e1f-4b04-cf83-604474af2775	2026-04-30	Boxed warning, Warnings, Adverse reactions	Name fallback manufacturer name: Hospira, Inc.
Aminocaproic Acid	AMINOCAPROIC ACID	Hospira, Inc.	1c5bc1dd-e9ec-44c1-9281-67ad482315d9	2026-04-30	Warnings, Adverse reactions	Name fallback manufacturer name: Hospira, Inc.
Verapamil Hydrochloride	VERAPAMIL HYDROCHLORIDE	Hospira, Inc.	70057a53-ca29-4848-ab3d-5e691e2a14a3	2026-04-29	Warnings, Adverse reactions	Name fallback manufacturer name: Hospira, Inc.
Potassium Acetate	POTASSIUM ACETATE	Hospira, Inc.	c58f8112-d587-493a-91b7-2b48c80bb7bf	2026-04-27	Warnings, Adverse reactions	Name fallback manufacturer name: Hospira, Inc.
Potassium Acetate	POTASSIUM ACETATE	Hospira, Inc.	e9772b82-1e2b-4c4b-aa47-677491dbf73c	2026-04-27	Warnings, Adverse reactions	Name fallback manufacturer name: Hospira, Inc.
Gemcitabine	GEMCITABINE	Hospira, Inc.	dc02a23b-3ff9-4441-aa91-8e9e629a7315	2026-04-27	Warnings, Adverse reactions	Name fallback manufacturer name: Hospira, Inc.
Potassium Acetate	POTASSIUM ACETATE	Hospira, Inc.	c7eabefd-2781-439b-b8f4-cb3ea25a4720	2026-04-27	Warnings, Adverse reactions	Name fallback manufacturer name: Hospira, Inc.
Gemcitabine	GEMCITABINE	Hospira, Inc.	e18ed1cb-7dd0-4001-bfda-17d1f4587fb8	2026-04-27	Warnings, Adverse reactions	Name fallback manufacturer name: Hospira, Inc.
Sodium Chloride	SODIUM CHLORIDE	Sportpharm LLC	a2c111f6-74d5-4a5d-82ac-d0f237488cb8	2026-04-24	Warnings, Adverse reactions	Name fallback brand name: Sodium Chloride
Sodium Chloride	SODIUM CHLORIDE	Method Pharmaceuticals, LLC	4b08859e-65bd-8255-e063-6394a90af614	2026-04-23	Warnings	Name fallback brand name: Sodium Chloride
Magnesium Sulfate	MAGNESIUM SULFATE	Hospira, Inc.	d4b5863a-efb9-4551-a9ad-2b06e8666d87	2026-04-23	Warnings, Adverse reactions	Name fallback manufacturer name: Hospira, Inc.
Morphine Sulfate	MORPHINE SULFATE	Hospira, Inc.	1d181906-f3ec-4222-1883-e61577a3122e	2026-04-21	Boxed warning, Warnings, Adverse reactions	Name fallback manufacturer name: Hospira, Inc.
Mannitol	MANNITOL	Hospira, Inc.	8ad3145e-00e7-4412-b9a5-06f00f264f30	2026-04-21	Warnings, Adverse reactions	Name fallback manufacturer name: Hospira, Inc.
Hydromorphone Hydrochloride	HYDROMORPHONE HYDROCHLORIDE	Hospira, Inc.	3832ede8-d3fc-455d-ecab-3b77be5869f5	2026-04-21	Boxed warning, Warnings, Adverse reactions	Name fallback manufacturer name: Hospira, Inc.
ROCURONIUM BROMIDE	ROCURONIUM BROMIDE	Hospira, Inc.	cccd40ca-5f08-4acb-8548-3cad558388bb	2026-04-15	Warnings, Adverse reactions	Name fallback manufacturer name: Hospira, Inc.
Midazolam	MIDAZOLAM HYDROCHLORIDE	Hospira, Inc.	affecd4d-1f78-4bbe-5a8d-86849bbdc520	2026-04-15	Boxed warning, Warnings, Adverse reactions	Name fallback manufacturer name: Hospira, Inc.
MANGANESE	MANGANESE CHLORIDE	Hospira, Inc.	6e979070-5035-4076-e09c-b52466be3c68	2026-04-15	Warnings, Adverse reactions	Name fallback manufacturer name: Hospira, Inc.
Metoclopramide	METOCLOPRAMIDE	Hospira, Inc.	373ba08b-33ad-49fc-28a7-928e89a65314	2026-04-14	Boxed warning, Warnings, Adverse reactions	Name fallback manufacturer name: Hospira, Inc.
BUPIVACAINE HYDROCHLORIDE	BUPIVACAINE HYDROCHLORIDE	Hospira, Inc.	bb44c7e1-d911-4788-908f-09b7b271969b	2026-04-14	Boxed warning, Warnings, Adverse reactions	Name fallback manufacturer name: Hospira, Inc.

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.